Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestine, Small | 3 | 2019 | 299 | 1.060 |
Why?
|
| Crohn Disease | 3 | 2016 | 764 | 0.910 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 79 | 0.720 |
Why?
|
| Colitis, Ulcerative | 3 | 2016 | 760 | 0.680 |
Why?
|
| Heavy Chain Disease | 1 | 2018 | 1 | 0.610 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2019 | 239 | 0.520 |
Why?
|
| Capsule Endoscopy | 2 | 2019 | 33 | 0.500 |
Why?
|
| Overweight | 1 | 2016 | 119 | 0.500 |
Why?
|
| Seasons | 1 | 2016 | 240 | 0.480 |
Why?
|
| Cardiomegaly | 1 | 2015 | 120 | 0.470 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 163 | 0.460 |
Why?
|
| Dietary Fiber | 1 | 2014 | 44 | 0.450 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2014 | 85 | 0.450 |
Why?
|
| Stress, Physiological | 1 | 2015 | 232 | 0.430 |
Why?
|
| Celiac Disease | 1 | 2016 | 214 | 0.430 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 314 | 0.410 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 979 | 0.410 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 360 | 0.400 |
Why?
|
| Carrier Proteins | 1 | 2015 | 679 | 0.380 |
Why?
|
| Hospitalization | 1 | 2016 | 888 | 0.360 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 728 | 0.360 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 953 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 716 | 0.340 |
Why?
|
| Obesity | 1 | 2016 | 972 | 0.330 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 50 | 0.280 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 37 | 0.280 |
Why?
|
| Caspase 3 | 1 | 2007 | 162 | 0.280 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 3682 | 0.240 |
Why?
|
| Biopsy | 2 | 2018 | 1185 | 0.210 |
Why?
|
| Subacute Care | 1 | 2021 | 15 | 0.190 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 108 | 0.180 |
Why?
|
| Retrospective Studies | 6 | 2021 | 9239 | 0.180 |
Why?
|
| Apoptosis | 1 | 2007 | 1718 | 0.180 |
Why?
|
| Mothers | 1 | 2021 | 145 | 0.170 |
Why?
|
| Female | 11 | 2021 | 46620 | 0.160 |
Why?
|
| Inpatients | 1 | 2021 | 312 | 0.160 |
Why?
|
| Adult | 7 | 2018 | 26845 | 0.150 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2018 | 11 | 0.150 |
Why?
|
| Nutritional Sciences | 1 | 2018 | 13 | 0.150 |
Why?
|
| Nutrition Therapy | 1 | 2018 | 10 | 0.150 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2018 | 96 | 0.150 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2018 | 133 | 0.150 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 163 | 0.140 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 164 | 0.140 |
Why?
|
| Gastroenterologists | 1 | 2018 | 31 | 0.140 |
Why?
|
| Middle Aged | 8 | 2021 | 26179 | 0.140 |
Why?
|
| Humans | 15 | 2021 | 90014 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1731 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 127 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1602 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 111 | 0.130 |
Why?
|
| Anthrax | 2 | 2007 | 30 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2018 | 147 | 0.130 |
Why?
|
| Male | 9 | 2021 | 42705 | 0.120 |
Why?
|
| Certolizumab Pegol | 1 | 2014 | 19 | 0.120 |
Why?
|
| Cell Nucleus | 2 | 2015 | 601 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 594 | 0.110 |
Why?
|
| Infant | 2 | 2021 | 3189 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 403 | 0.110 |
Why?
|
| Histones | 1 | 2015 | 333 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2016 | 776 | 0.100 |
Why?
|
| Remission Induction | 1 | 2014 | 741 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 174 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2016 | 906 | 0.100 |
Why?
|
| Smoking | 1 | 2016 | 625 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 244 | 0.100 |
Why?
|
| Incidence | 1 | 2016 | 1604 | 0.100 |
Why?
|
| Aged | 5 | 2019 | 19269 | 0.100 |
Why?
|
| Risk Factors | 3 | 2019 | 5566 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 6784 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 745 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1929 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2015 | 666 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2016 | 2494 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2017 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 743 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2016 | 3773 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1243 | 0.080 |
Why?
|
| Mice | 3 | 2015 | 11869 | 0.080 |
Why?
|
| Pneumonia | 2 | 2007 | 183 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1395 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 13 | 0.070 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2007 | 25 | 0.070 |
Why?
|
| bcl-Associated Death Protein | 1 | 2007 | 16 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2007 | 53 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 46 | 0.070 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2007 | 37 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2007 | 73 | 0.070 |
Why?
|
| Prognosis | 1 | 2014 | 3794 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2007 | 64 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 194 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 696 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1801 | 0.060 |
Why?
|
| Adolescent | 2 | 2016 | 9352 | 0.060 |
Why?
|
| Cross Infection | 1 | 2006 | 151 | 0.060 |
Why?
|
| Child | 1 | 2016 | 7241 | 0.060 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2004 | 12 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2004 | 18 | 0.060 |
Why?
|
| Clostridium Infections | 1 | 2006 | 125 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2005 | 230 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 538 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 107 | 0.050 |
Why?
|
| Animals | 3 | 2015 | 27551 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 146 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 164 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2021 | 326 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 365 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 6423 | 0.050 |
Why?
|
| New Jersey | 1 | 2021 | 4 | 0.050 |
Why?
|
| New York | 1 | 2021 | 73 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2005 | 530 | 0.050 |
Why?
|
| Lactation | 1 | 2021 | 54 | 0.050 |
Why?
|
| Milk, Human | 1 | 2021 | 46 | 0.050 |
Why?
|
| Time Factors | 2 | 2007 | 5362 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 700 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 846 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1912 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 384 | 0.040 |
Why?
|
| Ileum | 1 | 2019 | 168 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 8295 | 0.040 |
Why?
|
| Length of Stay | 1 | 2021 | 751 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 867 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 281 | 0.030 |
Why?
|
| Infliximab | 1 | 2014 | 159 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 572 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4326 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 785 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2007 | 1869 | 0.020 |
Why?
|
| Hematocrit | 1 | 2007 | 68 | 0.020 |
Why?
|
| Rehabilitation Centers | 1 | 2006 | 8 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 126 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 359 | 0.020 |
Why?
|
| Rectum | 1 | 2006 | 148 | 0.020 |
Why?
|
| Emergencies | 1 | 2005 | 122 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 809 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 33 | 0.010 |
Why?
|
| Spores, Bacterial | 1 | 2004 | 18 | 0.010 |
Why?
|
| Aerosols | 1 | 2004 | 47 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 65 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 68 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 78 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 193 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 200 | 0.010 |
Why?
|
| Bacillus anthracis | 1 | 2004 | 73 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 285 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 409 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 657 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 793 | 0.010 |
Why?
|
| Ischemia | 1 | 2004 | 253 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1250 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 573 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2004 | 340 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 469 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2004 | 738 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1579 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 1311 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 3406 | 0.010 |
Why?
|